Tuesday 25 April 2023
CX Vascular.com
Join the community #CX2023
CX continues looking forward after 45 years of leading vascular education, innovation and evidence
CX 2023 OVERVIEW
DAY ONE
Peripheral Arterial Consensus
Peripheral Arterial & Acute Limb Ischaemia & Randomised Control Trial Update Tuesday, 08:00–13:00 Kensington 1
Peripheral Arterial Consensus
Welcome to the 2023 edition of the Charing Cross (CX) International Symposium. After the overwhelming success of the first ever combined in-person and virtual symposium in 2022, CX continues looking forward to offer world-leading education and evidence on the pressing issues in the vascular and endovascular space in what is now its 45th year.
A
s an attendee, you can expect a comprehensive programme across all vascular domains including peripheral arterial, aortic, venous and lymphatic, vascular access, acute stroke, vascular trauma and—making its debut in 2023—the wide field of renal interventions. This year’s programme highlights include a consensus update on key topics in the vascular and endovascular space—from revascularisation strategies for patients with chronic limb-threatening ischaemia (CLTI), to treatment options for superficial venous disease. “If you have an interest in and are managing patients with vascular disease, there is something for you at CX,” CX founder and chairman Roger Greenhalgh (London, United Kingdom) tells CX Daily News, highlighting the multidisciplinary participation at the meeting. Eighteen Podium First presentations, over 38 live and edited cases, and two CX debates punctuate the three-day agenda of over 300 podium presentations to offer a comprehensive educational experience. The pillars of CX—Education, Innovation, and Evidence—will take centre stage across three rooms, Kensington 1, Kensington 2, and Admiral. In the long-established CX style, the meeting will champion a global audience and dedicate a significant CXVASCULAR-APRIL-2023-225X58.pdf 1 07/04/2023 15:40:00 proportion of time to audience participation, including discussion and
Peripheral Arterial & Chronic Limb Threatening Ischaemia (CLTI) Tuesday, 13:30–18:00 Kensington 1 Clockwise from top left: Dittmar polling, while attendees can also expect a series of activities beyond Böckler, Andrew Holden, Roger Greenhalgh and Erin Murphy the main programme, including workshop demonstrations and the CX exhibition. Reflecting its ongoing evolution, CX welcomes three new cochairs from across the globe to the leadership team for 2023. Dittmar Böckler (Heidelberg, Germany), Andrew Holden (Auckland, New Zealand) and Erin Murphy (Charlotte, United States) are working alongside Greenhalgh to deliver the CX programme. “We are covering the globe and all vascular subjects,” he says of the new leadership team. “There will be every opportunity for the CX concept to continue if that is considered to be worthwhile.” The centrepiece highlight of this year’s programme is the BASIL-2 (Bypass versus angioplasty in severe ischaemia of the leg-2) Podium First presentation, taking place during a Randomised Control Trial Update Session in Kensington 1 beginning at 11:10 this morning (Day One). “At the moment of speaking, publication of the results
If you have an interest in and are managing patients with vascular disease, there is something for you at CX.” Continued on page 2
C
Joi n our gl obal onl i ne v as cul ar c o m m u n i t y
M
Y
CM
MY
CY
CMY
K
VA S C U L A R
S I G N U P AT
C X VA S C U L A R . C O M Education, News and Insights for the global vascular community
Aortic Consensus
Aortic Techniques & Technologies Tuesday, 08:00–18:00 Kensington 2
Vascular Access Consensus
Vascular Access Tuesday, 08:00–13:00 Admiral
Renal Interventions Consensus
Renal Interventions Tuesday, 13:30–18:00 Admiral